First Trust NYSE Arca Biotechnology Index Fund | |
$ 171.3 | |
Last Holding update 2024-11-26 | 30 Stocks (1 new) |
Value $1.21 Bil | Turnover 9 % |
Portfolio Report | |
Registrant: FIRST TRUST EXCHANGE-TRADED FUND
|
Performance
Annualized Return %
Total Annual Return %
Key Statistics
Name | Value | ||
---|---|---|---|
Day's Open ($) | 169.93 | ||
Day's Range ($) | 169.45 - 171.3499 | ||
Day's Volume | 19,996 | ||
52-Week Range ($) | 140.36 - 179.67 | ||
Beta | 0.73 | ||
Volatility | 15.07 | ||
14-Day RSI | 55.75 | ||
14-Day ATR ($) | 2.568124 | ||
20-Day SMA ($) | 168.42417 |
Fundamental Data
Name | Value | ||
---|---|---|---|
Market Cap (Mil $) | 1,147.71 | ||
Shares Outstanding (Mil) | 6.7 | ||
PE Ratio | 24.48 | ||
PE Ratio (10y Range) | 15.1 - 31.2 | ||
PE Ratio (10y Median) | 21.9 | ||
PB Ratio | 5.1 | ||
PB Ratio (10y Range) | 3.46 - 6.41 | ||
PB Ratio (10y Median) | 4.95 |
Dividend Data
Name | Value | ||
---|---|---|---|
Dividends per Share (TTM) ($) | 4.69 | ||
Dividend Yield % | 2.74 | ||
Dividend Yield % (10y Range) | 1.33 - 2.85 | ||
Dividend Yield % (10y Median) | 2.8 | ||
Next Dividend Payment Date | |||
Dividend Frequency | Quarterly |
FBT First Trust NYSE Arca Biotechnology Index Fund Fundamental Charts
Historical TTM Price-to-Earnings for FBT First Trust NYSE Arca Biotechnology Index Fund
Historical TTM Price-to-Earnings without NRI for FBT First Trust NYSE Arca Biotechnology Index Fund
Historical Price-to-Book Ratio for FBT First Trust NYSE Arca Biotechnology Index Fund
Historical Dividend Yields for FBT First Trust NYSE Arca Biotechnology Index Fund
FBT First Trust NYSE Arca Biotechnology Index Fund Technical Indicators
Moving Average
Momentum
Gurus Latest Trades with ARCA:FBT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
ARCA:FBT is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
First Trust NYSE Arca Biotechn... Top Holdings of 2024-09-30
View Full List
Ticker | | Company | Shares | Value ($1000) | Shares Change % | Weighting % | Trade Impact % | % of Shares outstanding | 3M Change % | YTD Change % | Market Cap $Mil | Industry |
---|---|---|---|---|---|---|---|---|---|---|---|---|
ONC | BeiGene Ltd | 246,026 | 55235.300 | -1.27% | 4.580 | -0.04% | 0.230 | -26.18% | -4.33% | 20199.111 | Biotechnology | |
EXAS | Exact Sciences Corp | 807,541 | 55009.690 | +63.62% | 4.560 | +1.77% | 0.440 | -18.52% | +0.55% | 10456.811 | Medical Diagnostics & Research | |
CORT | Corcept Therapeutics Inc | 1,188,496 | 55003.590 | -20.64% | 4.560 | -0.91% | 1.130 | +10.17% | -1.07% | 5223.041 | Biotechnology | |
BNTX | BioNTech SE | 440,701 | 52342.060 | +8.24% | 4.340 | +0.33% | 0.180 | +3.78% | +7.81% | 29452.059 | Biotechnology | |
CPRX | Catalyst Pharmaceuticals Inc | 2,257,996 | 44888.960 | -2.40% | 3.720 | -0.08% | 1.890 | +10.10% | +5.03% | 2614.474 | Biotechnology | |
GILD | Gilead Sciences Inc | 535,130 | 44865.300 | +3.45% | 3.720 | +0.12% | 0.040 | +7.05% | -2.70% | 112014.375 | Drug Manufacturers | |
WAT | Waters Corp | 123,802 | 44555.100 | +13.45% | 3.690 | +0.44% | 0.210 | +7.86% | +2.53% | 22583.728 | Medical Diagnostics & Research | |
ALKS | Alkermes PLC | 1,588,359 | 44458.170 | +10.16% | 3.690 | +0.34% | 0.980 | +2.59% | -2.36% | 4543.414 | Drug Manufacturers | |
RGEN | Repligen Corp | 297,312 | 44245.970 | +44.84% | 3.670 | +1.14% | 0.530 | +15.15% | +7.59% | 8676.299 | Medical Devices & Instruments | |
ARGX | argenx SE | 80,267 | 43511.140 | -13.82% | 3.610 | -0.50% | 0.130 | +24.47% | +6.71% | 39652.497 | Biotechnology |
First Trust NYSE Arca Biotechnology Index Fund's Historical Top Holdings Breakdowns
First Trust NYSE Arca Biotechnology Index Fund's Top Stock Picks
View Full List
Ticker | | Company | Date | Action | Impact % | Price Range | Price | Price Change from Avrg% | Comment | Current Shares | Share Change |
---|---|---|---|---|---|---|---|---|---|---|---|
NTRA | Natera Inc | 2024-03-31 | New Buy | +4.96% | 59.21 ($75.21) 92.9 | $175.00 | 132.68% | New holding | 634,745 | 634,745 | |
BRKR | Bruker Corp | 2024-03-31 | New Buy | +4.36% | 69.21 ($80.45) 94.27 | $60.78 | -24.45% | New holding | 542,530 | 542,530 | |
RARE | Ultragenyx Pharmaceutical Inc | 2024-03-31 | Sold Out | -4.23% | 43.02 ($47.17) 53.69 | $42.07 | -10.81% | Sold Out | 0 | -1,139,197 | |
GRFS | Grifols SA | 2024-03-31 | Sold Out | -4.19% | 5.47 ($7.81) 11.38 | $7.29 | -6.66% | Sold Out | 0 | -4,663,808 | |
HALO | Halozyme Therapeutics Inc | 2024-03-31 | New Buy | +3.90% | 33.68 ($37.49) 41.95 | $52.80 | 40.84% | New holding | 1,122,560 | 1,122,560 | |
CRL | Charles River Laboratories International Inc | 2024-03-31 | Sold Out | -3.74% | 203.52 ($238.81) 273.43 | $186.12 | -22.06% | Sold Out | 0 | -203,496 | |
WAT | Waters Corp | 2024-03-31 | New Buy | +3.69% | 302.51 ($328.72) 361 | $380.35 | 15.71% | New holding | 125,499 | 125,499 | |
IQV | IQVIA Holdings Inc | 2024-03-31 | Sold Out | -3.68% | 208.23 ($233.46) 259.1 | $203.27 | -12.93% | Sold Out | 0 | -204,655 | |
CORT | Corcept Therapeutics Inc | 2024-03-31 | New Buy | +3.59% | 21.1 ($23.63) 27.46 | $49.85 | 110.96% | New holding | 1,665,935 | 1,665,935 | |
TECH | Bio-Techne Corp | 2024-03-31 | Sold Out | -3.53% | 65.98 ($71.55) 77.09 | $73.31 | 2.46% | Sold Out | 0 | -588,890 |
First Trust NYSE Arca Biotechnology Index Fund Total Holding History ($B)
First Trust NYSE Arca Biotechnology Index Fund's Asset Allocation
First Trust NYSE Arca Biotechnology Index Fund Past Portfolios
Portfolio Date | Number of Stocks | New Stocks | Total Value ($Mil) | Q/Q Turnover |
---|---|---|---|---|
Top Ranked Articles
- 1
First Trust NYSE Arca Biotechnology Index Fund's Hypothetical Growth since 2024-09-30
First Trust NYSE Arca Biotechnology Index Fund's Yearly Returns
Year | Portfolio % | % | Excess Gain % |
---|
First Trust NYSE Arca Biotechnology Index Fund's Holdings Heat Map
Size field:
First Trust NYSE Arca Biotechnology Index Fund's Holdings Bubble Chart
First Trust NYSE Arca Biotechnology Index Fund News
- 1
Discussions on First Trust NYSE Arca Biotechnology Index Fund
No discussions yet.